A detailed history of Exchange Traded Concepts, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 13,704 shares of EW stock, worth $1.03 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
13,704
Previous 16,501 16.95%
Holding current value
$1.03 Million
Previous $1.52 Million 40.68%
% of portfolio
0.02%
Previous 0.04%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$59.7 - $93.78 $166,980 - $262,302
-2,797 Reduced 16.95%
13,704 $904,000
Q2 2024

Aug 13, 2024

SELL
$84.3 - $94.31 $83,625 - $93,555
-992 Reduced 5.67%
16,501 $1.52 Million
Q1 2024

Apr 15, 2024

SELL
$72.54 - $95.56 $331,072 - $436,135
-4,564 Reduced 20.69%
17,493 $1.67 Million
Q4 2023

Jan 05, 2024

SELL
$61.71 - $77.76 $75,162 - $94,711
-1,218 Reduced 5.23%
22,057 $1.68 Million
Q3 2023

Oct 18, 2023

SELL
$69.28 - $93.38 $2.25 Million - $3.03 Million
-32,478 Reduced 58.25%
23,275 $1.61 Million
Q2 2023

Jul 20, 2023

BUY
$81.41 - $94.33 $2.47 Million - $2.86 Million
30,320 Added 119.22%
55,753 $5.26 Million
Q1 2023

Apr 12, 2023

BUY
$74.26 - $84.51 $64,606 - $73,523
870 Added 3.54%
25,433 $2.1 Million
Q4 2022

Jan 17, 2023

BUY
$68.3 - $87.44 $156,133 - $199,887
2,286 Added 10.26%
24,563 $1.83 Million
Q3 2022

Oct 07, 2022

BUY
$82.37 - $107.29 $168,034 - $218,871
2,040 Added 10.08%
22,277 $1.84 Million
Q2 2022

Jul 20, 2022

SELL
$86.5 - $128.27 $393,661 - $583,756
-4,551 Reduced 18.36%
20,237 $1.92 Million
Q1 2022

Apr 26, 2022

SELL
$101.96 - $128.34 $443,118 - $557,765
-4,346 Reduced 14.92%
24,788 $2.92 Million
Q4 2021

Jan 13, 2022

SELL
$106.37 - $130.68 $529,616 - $650,655
-4,979 Reduced 14.6%
29,134 $3.77 Million
Q3 2021

Oct 18, 2021

BUY
$102.91 - $122.75 $140,883 - $168,044
1,369 Added 4.18%
34,113 $3.86 Million
Q2 2021

Jul 30, 2021

BUY
$83.84 - $104.76 $442,172 - $552,504
5,274 Added 19.2%
32,744 $3.39 Million
Q1 2021

Apr 20, 2021

BUY
$78.68 - $90.67 $717,482 - $826,819
9,119 Added 49.69%
27,470 $2.3 Million
Q4 2020

Jan 19, 2021

BUY
$71.69 - $91.23 $727,581 - $925,893
10,149 Added 123.74%
18,351 $1.67 Million
Q3 2020

Oct 30, 2020

BUY
$67.19 - $87.44 $219,240 - $285,316
3,263 Added 66.07%
8,202 $655,000
Q2 2020

Jul 15, 2020

BUY
$57.54 - $76.95 $100,695 - $134,662
1,750 Added 54.88%
4,939 $341,000
Q1 2020

Apr 14, 2020

BUY
$52.41 - $81.0 $16,666 - $25,758
318 Added 11.08%
3,189 $602,000
Q4 2019

Jan 22, 2020

BUY
$71.7 - $82.09 $205,850 - $235,680
2,871 New
2,871 $670,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.